Public health

#AI / data analytics / healthtech / informatics #Drug development #Events #Medtech #Public health

Back in-person for 2022: LSX World Congress returns

For the last seven years, the LSX World Congress has bought together biotech, medtech and healthtech executives to connect with the capital, intelligence, innovation, and partners they need to grow their businesses. Back in-person for 2022, the 8th Congress takes place 10-11 May at 133 Houndsditch in London. … Read More

#News #Trending News

#Clinical trials #Covid-19 #Healthcare #HIV #Malaria #Public health

World Health Day: We celebrate global drug discovery

As we celebrate World Health Day, Lu Rahman looks at some of the key drug discovery and development successes over the last year that have significantly helped improved the health and wellbeing of the global population.   Malaria breakthroughs  According to The World Health Organization (WHO) more than a million people in Africa… Read More

#Editor's Choice #Exclusive Content #News

#Clinical trials #Covid-19 #Healthcare #Public health

Interview: Delivering smart clinical trials for better health 

Following the launch of Protas, an organisation which was launched on January 24, 2022, DDW Editorial Assistant Megan Thomas interviews Protas Chief Executive, Professor Sir Martin Landray, an epidemiologist and physician who has over 20 years’ experience of leading large, randomised clinical trials and has most recently been leading the… Read More

#Covid-19 #Exclusive Content #News #Opinion

#AI / data analytics / healthtech / informatics #Drug development #Events #Medtech #Public health

Life Science community gathers in London for key partnering event 

For the last seven years, the LSX World Congress has bought together biotech, medtech and healthtech executives to connect with the capital, intelligence, innovation, and partners they need to grow their businesses. Back in-person for 2022, the 8th Congress takes place 10-11 May at 133 Houndsditch in London. … Read More

#News #Trending News

#Collaboration #Infectious diseases #Public health

European Clinical Research Alliance for Infectious Diseases created 

In January 2022, European Clinical Research Alliance for Infectious Diseases (Ecraid) became a legal entity and is now fully operational to advance knowledge in the field of infectious diseases. This is Ecraid’s initial step as it evolves into a self-sustaining, not-for-profit organisation conducting clinical research for both public and… Read More

#News

#Life sciences #Market reporting #Pharmaceutical research #Public health

How strong is the digital talent in the global pharma sector? 

DDW's Megan Thomas looks at three regions and their approach to digitalisation. 1. United Kingdom  A report published by the Association of the British Pharmaceutical Industry (ABPI) has identified the skills and training conditions needed for the future success of UK life sciences. George Freeman, Minister for Science, Research, and… Read More

#News #Trends & Analysis

#Approvals #Collaboration #Drug discovery #Public health #Research study

This week in drug discovery (14-18 February) 

News round-up by DDW’s Megan Thomas for 14-18 February, 2022  This week, DDW rounds up updates, approvals, research and trials which will enable scientists to make life-saving developments in the drug discovery industry.  1. Trial launched of HIV vaccine antigens delivered through mRNA technology… Read More

#News

#Covid-19 #Public health #Research study

SARS-CoV-2 human challenge studies are safe in healthy young adults 

Open Orphan has released the results from its Covid-19 characterisation study, which was a partnership between hVIVO, Imperial College London, the Vaccine Taskforce and Department of Health and Social Care (DHSC), and the Royal Free London NHS Foundation Trust. The results from this study show that a SARS-CoV-2 human… Read More

#News

#Metabolomics #Public health

Collaboration powers metabolomic enriched population health studies 

Metabolon has collaborated with the FinnGen study in Finland to provide metabolomics data for population health studies to improve understanding of human health.  Why collaborate?  FinnGen will incorporate deep metabolomic datasets to better understand how genetic drivers of disease may impact biological function and influence… Read More

#News

#Cancer #Cancer research #Comment #Healthcare #Public health

Close the care gap: World Cancer Day 2022 

2022's World Cancer Day theme is “Close the Care Gap”1 and is focused on raising awareness of the cancer care equity gap that affects almost everyone, in high as well as low- and middle-income countries, and costs lives. DDW’s Megan Thomas comments on the crisis as well as initiatives that are working to close this… Read More

#Cancer Research #Editor's Choice #Intelligence #News #Opinion #Trends & Analysis

#Cancer research #Healthcare #Public health #Regulatory

Leukaemia patients granted early access to investigational treatment 

Novartis UK has announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has given a positive scientific opinion for the investigational treatment asciminib to be made available to appropriate patients under the UK Early Access to Medicines Scheme (EAMS).1  What does this mean?  The… Read More

#News

#AI / data analytics / healthtech / informatics #Comment #Healthcare #Public health

Expert perspective: 2022 challenges and opportunities

DDW’s Megan Thomas speaks to decision-makers from the drug discovery industry about their predictions on what 2022 holds for our sector.   Around this time last year, the first Covid-19 vaccines were authorised for emergency use by organisations such as the FDA1, the EMA2, the MHRA3 and many more internationally. Read More

#Editor's Choice #Exclusive Content #Intelligence #News #Opinion #Trends & Analysis

#Clinical trials #Healthcare #Public health #Training

Psychotherapists begin training for treatment resistant depression trials 

Beckley Psytech has announced that the first cohort of psychotherapists have begun training in advance of the expected Phase II clinical trial examining 5-MeO-DMT-assisted psychotherapy in treatment resistant depression (TRD).   The training  The training is being conducted in collaboration with Fluence, an educational platform that provides professional… Read More

#News

#AI / data analytics / healthtech / informatics #Informatics #Laboratory data #Public health

Combined group to improve outcomes in diagnostics and lab informatics  

CliniSys has acquired Horizon Lab Systems and combined with Sunquest Information Systems, to create an organisation dedicated to diagnostic and laboratory informatics.  Outlook  CliniSys’ vision is to embrace a new wave of digital diagnostics and laboratories across the continuum of care and community to improve public health.  Horizon… Read More

#News #Trending News

#Drug discovery #Funding #Healthcare #Investment #Life sciences #Public health

Drug discovery investors: Who’s spending? 

While the research, results and trials often take centre-stage when it comes to drug discovery and development reporting, DDW’s Megan Thomas spotlights the funding and investments which make this possible.   1. US researcher awarded $3.6 million to study antibiotic resistance  Sanford Burnham Prebys professor Andrei Osterman, Ph.D., has been awarded a $3.6 million… Read More

#Business & Investment #Editor's Choice #Exclusive Content #News

#Comment #Covid-19 #Genetics #Genomics #Public health #Research

Genomics boosts understanding of Covid-19 severity and susceptibility

Listen to this article on the DDW Podcast: The Covid-19 Host Genetics Initiative carried out one of the largest genome-wide association studies ever. It involved meta-analysis of nearly 50,000 Covid-19 patients and two million uninfected controls. Dr Hamdi Mbarek, Lead Analyst of the Qatari dataset explains how the initiative improved knowledge… Read More

#Covid-19 #Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis